What is Erste Group Bank's Estimate for JNJ FY2026 Earnings?
Johnson & Johnson (NYSE:JNJ - Free Report) - Equities research analysts at Erste Group Bank raised their FY2026 earnings estimates for Johnson & Johnson in a research report issued on Monday, April...
MarketBeat·3h ago
More News
Directional Asset Management Invests $3.02 Million in Johnson & Johnson $JNJ
Directional Asset Management acquired a new position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing...
MarketBeat·7h ago
Johnson & Johnson $JNJ Shares Purchased by Calamos Advisors LLC
Calamos Advisors LLC lifted its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 1.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned...
MarketBeat·7h ago
Johnson & Johnson (NYSE:JNJ) Trading 1% Higher - Should You Buy?
Johnson & Johnson (NYSE:JNJ) Trading 1% Higher - Time to Buy...
MarketBeat·17h ago
Healthcare Stocks To Watch Today - April 28th
UnitedHealth Group, Johnson & Johnson, Centene, Hims & Hers Health, and HCA Healthcare are the five Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks...
MarketBeat·19h ago
Promising Medical Stocks To Follow Today - April 28th
UnitedHealth Group, Arcellx, Eli Lilly and Company, Pfizer, and Johnson & Johnson are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares...
MarketBeat·19h ago
J&J Sees Continued MedTech Improvement in Q1, Eyes Better 2026
J&J's MedTech unit gains momentum in Q1, but China headwinds linger. Can new products and portfolio shifts drive stronger growth in 2026?
Zacks·23h ago
Arizona State Retirement System Lowers Stake in Johnson & Johnson $JNJ
Arizona State Retirement System trimmed its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 3.3% in the fourth quarter, according to its most recent filing with the Securities and...
MarketBeat·1d ago
Johnson & Johnson $JNJ Shares Sold by Absher Wealth Management LLC
Absher Wealth Management LLC trimmed its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 14.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 160,607 shares of the company's stock after selling 26,490 shares during the quar...
MarketBeat·1d ago
Top Medical Stocks To Consider - April 27th
UnitedHealth Group, Organon & Co., Eli Lilly and Company, Abbott Laboratories, Johnson & Johnson, AbbVie, and Boston Scientific are the seven Medical stocks to watch today, according to MarketBeat's...